Recent Patents on Endocrine, Metabolic & Immune Drug Discovery

Continued as New Advances on Endocrine Metabolic and Immune Diseases

Personal Subscription
Volume: 1 Issue: 3, November

Signaling Pathways Involved in Physiopathology of Pancreatic β -Cells

Volume:1   Issue: 3
Pp: 180-192
Stephane Dalle, Safia Costes, Julie Quoyer, Gyslaine Bertrand and Christophe Broca
DOI: 10.2174/187221407782409116
Published on: 01 March, 2012

GLP-1 as a Therapeutic Agent in Patients with Type 2 Diabetes Mellitus

Volume:1   Issue: 3
Pp: 193-201
Ioannis Legakis
DOI: 10.2174/187221407782409107
Published on: 01 March, 2012

Anti-Thrombotic Properties of Tomato

Volume:1   Issue: 3
Pp: 202-209
Asim K. Duttaroy
DOI: 10.2174/187221407782409125
Published on: 01 March, 2012

Therapeutic Use of Antioxidants in Sepsis

Volume:1   Issue: 3
Pp: 210-223
Andre L. Rosario and Luciano C.P. Azevedo
DOI: 10.2174/187221407782409071
Published on: 01 March, 2012

The Sodium Pump: Bridging the Basic and Clinical Cardiovascular Sciences

Volume:1   Issue: 3
Pp: 224-246
Donald M. Foster, Suresh K. Verma, Hind Lal, John C. Reneau, Manuela Smith and David E. Dostal
DOI: 10.2174/187221407782409099
Published on: 01 March, 2012

Patents in Targets and Drugs for Insulin Resistance: Correlation with Inflammatory Mediators

Volume:1   Issue: 3
Pp: 247-254
Daniel S. de Carvalho, Fernando R. M. da Silva Seixas and Elizabeth P. Sampaio
DOI: 10.2174/187221407782409080
Published on: 01 March, 2012

Patent Selections

Volume:1   Issue: 3
Pp: 255-257
Bentham Science Publishers
DOI: 10.2174/187221407782409134
Published on: 01 March, 2012